There are 30 resources available
Peri-operative: Neoadjuvant and adjuvant in RCC
Presenter: A. Bex, UK
Session: Session 3 - Systemic Treatment in Renal Cell Cancer (RCC)
Resources:
Slides
Webcast
1st line treatment for clear-cell mRCC
Presenter: C. Porta, IT
Session: Session 3 - Systemic Treatment in Renal Cell Cancer (RCC)
Resources:
Slides
Webcast
2nd line treatment for cc mRCC and new agents
Presenter: L. Albiges, FR
Session: Session 3 - Systemic Treatment in Renal Cell Cancer (RCC)
Resources:
Slides
Webcast
Treatment for non-clear-cell mRCC
Presenter: C. Suarez, ES
Session: Session 3 - Systemic Treatment in Renal Cell Cancer (RCC)
Resources:
Slides
Webcast
Factors to inform L1 decision: IO-TKI
Presenter: V. Grünwald, DE
Session: Session 4 - Debate of the Day
Resources:
Slides
Webcast
Factors to inform L1 decision: IO-IO
Presenter: L. Albiges, FR
Session: Session 4 - Debate of the Day
Resources:
Slides
Webcast
Systemic treatment for NMIBC - Where do we stand?
Presenter: M. Roupret, FR
Session: Session 5 - NMIBC and Peri-operative Treatment in Localized MIBC
Resources:
Slides
Webcast
Neoadjuvant IO based treatment in MIBC
Presenter: Y. Loriot, FR
Session: Session 5 - NMIBC and Peri-operative Treatment in Localized MIBC
Resources:
Slides
Webcast
Adjuvant IO treatment in MIBC: The PRO’s and CON’s
Presenter: T. Powles, UK
Session: Session 5 - NMIBC and Peri-operative Treatment in Localized MIBC
Resources:
Slides
Webcast
Bladder cancer
Presenter: T. Powles, UK
Session: Session 6 - Biomarker Use to Inform Treatment Strategy
Resources:
Slides
Webcast